Zutrab (bevacizumab biosimilar)
/ Laboratorios Richmond
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 26, 2021
Argentina approves bevacizumab similar biological medicine Zutrab
(GaBI)
- "The Argentina-based Richmond Laboratory (Laboratorios Richmond) announced on 19 March 2021 that it had gained approval from Argentina’s National Administration of Drugs, Foods and Medical Devices (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica, ANMAT) for its similar biological medicine (medicamento biológico similar) Zutrab (bevacizumab)."
Non-US regulatory • Oncology
1 to 1
Of
1
Go to page
1